{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:55:07Z","timestamp":1792662907936,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.molmed.2018.06.009","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T14:38:13Z","timestamp":1531319893000},"page":"805-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Pluripotent Stem Cell Platforms for Drug Discovery"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2983-6330","authenticated-orcid":false,"given":"Kevin G.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeyoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela G.","family":"Robey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.G.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Gottesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2018.06.009_bib0005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0010","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.molmed.2018.06.009_bib0015","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.molmed.2018.06.009_bib0020","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.stem.2013.12.005","article-title":"Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics","volume":"14","author":"Chen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ncb3312","article-title":"Organoids as an in vitro model of human development and disease","volume":"18","author":"Fatehullah","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0035","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.scr.2014.02.002","article-title":"Developmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation","volume":"12","author":"Chen","year":"2014","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.molmed.2018.06.009_bib0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nbt.1615","article-title":"High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity","volume":"28","author":"Narva","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nbt922","article-title":"Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells","volume":"22","author":"Draper","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrc3034","article-title":"The tumorigenicity of human embryonic and induced pluripotent stem cells","volume":"11","author":"Ben-David","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2018.06.009_bib0055","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2018.06.009_bib0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nmeth.f.283","article-title":"Induced pluripotent stem cell technology for the study of human disease","volume":"7","author":"Lee","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molmed.2018.06.009_bib0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/clpt.2011.38","article-title":"The use of induced pluripotent stem cells in drug development","volume":"89","author":"Inoue","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2018.06.009_bib0070","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2013.07.001","article-title":"Phenotypic screens as a renewed approach for drug discovery","volume":"18","author":"Zheng","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.molmed.2018.06.009_bib0075","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.stemcr.2017.05.020","article-title":"The art of capturing pluripotency: creating the right culture","volume":"8","author":"Ying","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2018.06.009_bib0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nature05972","article-title":"New cell lines from mouse epiblast share defining features with human embryonic stem cells","volume":"448","author":"Tesar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2018.06.009_bib0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.stem.2009.05.015","article-title":"Naive and primed pluripotent states","volume":"4","author":"Nichols","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.scr.2012.06.003","article-title":"Non-colony type monolayer culture of human embryonic stem cells","volume":"9","author":"Chen","year":"2012","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.molmed.2018.06.009_bib0095","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nature04940","article-title":"Notch signalling regulates stem cell numbers in vitro and in vivo","volume":"442","author":"Androutsellis-Theotokis","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2018.06.009_bib0100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nbt1310","article-title":"A ROCK inhibitor permits survival of dissociated human embryonic stem cells","volume":"25","author":"Watanabe","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.5966\/sctm.2012-0081","article-title":"Adaptation to robust monolayer expansion produces human pluripotent stem cells with improved viability","volume":"2","author":"Kunova","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.molmed.2018.06.009_bib0110","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/nbt.2435","article-title":"Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression","volume":"30","author":"Lee","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0115","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.stem.2012.07.005","article-title":"Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay","volume":"11","author":"Hoing","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0120","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/stem.1430","article-title":"High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes","volume":"31","author":"Charbord","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2018.06.009_bib0125","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.molmed.2018.06.009_bib0130","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/1087057115588287","article-title":"High-throughput screening using iPSC-derived neuronal progenitors to identify compounds counteracting epigenetic gene silencing in fragile X syndrome","volume":"20","author":"Kaufmann","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.molmed.2018.06.009_bib0135","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents","volume":"301","author":"Ma","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kft113","article-title":"Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays","volume":"134","author":"Harris","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.molmed.2018.06.009_bib0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2015.03.008","article-title":"Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types","volume":"285","author":"Doherty","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0150","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.celrep.2014.09.055","article-title":"Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells","volume":"9","author":"Drawnel","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2018.06.009_bib0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/adt.2013.520","article-title":"High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells","volume":"12","author":"Sirenko","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0160","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1002\/hep.26237","article-title":"Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells","volume":"57","author":"Choi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2018.06.009_bib0165","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/toxsci\/kfv048","article-title":"Prediction of drug-induced liver injury in micropatterned co-cultures containing iPSC-derived human hepatocytes","volume":"145","author":"Ware","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.molmed.2018.06.009_bib0170","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1038\/srep08883","article-title":"Human iPSC-based cardiac microphysiological system for drug screening applications","volume":"5","author":"Mathur","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2018.06.009_bib0175","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1016\/j.biomaterials.2013.04.026","article-title":"Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.molmed.2018.06.009_bib0180","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.aaa5458","article-title":"Heart disease. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy","volume":"349","author":"Hinson","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.molmed.2018.06.009_bib0185","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.scr.2016.03.009","article-title":"Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen","volume":"16","author":"Carpentier","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.molmed.2018.06.009_bib0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrd4708","article-title":"Stem-cell discovery platforms yield first clinical candidates","volume":"14","author":"Mullard","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2018.06.009_bib0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nbt1285","article-title":"Adaptation to culture of human embryonic stem cells and oncogenesis in vivo","volume":"25","author":"Baker","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/clo.2006.8.16","article-title":"Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities","volume":"8","author":"Forsyth","year":"2006","journal-title":"Cloning Stem Cells"},{"key":"10.1016\/j.molmed.2018.06.009_bib0205","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.113.003638","article-title":"Extracellular matrix-mediated maturation of human pluripotent stem cell-derived cardiac monolayer structure and electrophysiological function","volume":"9","author":"Herron","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061173","article-title":"Differential sarcomere and electrophysiological maturation of human iPSC-derived cardiac myocytes in monolayer vs. aggregation-based differentiation protocols","volume":"18","author":"Jeziorowska","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2018.06.009_bib0215","doi-asserted-by":"crossref","DOI":"10.4161\/sgtp.29846","article-title":"Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions","volume":"5","author":"Julian","year":"2014","journal-title":"Small GTPases"},{"key":"10.1016\/j.molmed.2018.06.009_bib0220","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1124\/pr.115.010595","article-title":"Rho kinases in health and disease: from basic science to translational research","volume":"67","author":"Loirand","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.molmed.2018.06.009_bib0225","first-page":"51519","article-title":"Alternative cultures for human pluripotent stem cell production, maintenance, and genetic analysis","volume":"89","author":"Chen","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.molmed.2018.06.009_bib0230","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nmeth.1200","article-title":"Improved genetic manipulation of human embryonic stem cells","volume":"5","author":"Braam","year":"2008","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molmed.2018.06.009_bib0235","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1634\/stemcells.2006-0634","article-title":"Transient and stable transgene expression in human embryonic stem cells","volume":"25","author":"Liew","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2018.06.009_bib0240","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/stem.1195","article-title":"Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells","volume":"30","author":"Padmanabhan","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2018.06.009_bib0245","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature12271","article-title":"Vascularized and functional human liver from an iPSC-derived organ bud transplant","volume":"499","author":"Takebe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2018.06.009_bib0250","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/ncb2872","article-title":"Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells","volume":"15","author":"Xia","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0255","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/01.CIR.0000068356.38592.68","article-title":"Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells","volume":"107","author":"Mummery","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2018.06.009_bib0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ymeth.2008.10.015","article-title":"Micro-bioreactor arrays for controlling cellular environments: design principles for human embryonic stem cell applications","volume":"47","author":"Cimetta","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.molmed.2018.06.009_bib0265","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1039\/b820380f","article-title":"Microfluidic culture of single human embryonic stem cell colonies","volume":"9","author":"Villa-Diaz","year":"2009","journal-title":"Lab Chip"},{"key":"10.1016\/j.molmed.2018.06.009_bib0270","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1073\/pnas.1111478109","article-title":"Predictive microfluidic control of regulatory ligand trajectories in individual pluripotent cells","volume":"109","author":"Moledina","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2018.06.009_bib0275","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1039\/c3lc50435b","article-title":"Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device","volume":"13","author":"van der Meer","year":"2013","journal-title":"Lab Chip"},{"key":"10.1016\/j.molmed.2018.06.009_bib0280","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0285","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","article-title":"Disease modeling in stem cell-derived 3D organoid systems","volume":"23","author":"Dutta","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2018.06.009_bib0290","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a dish: modeling development and disease using organoid technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.molmed.2018.06.009_bib0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ydbio.2016.10.017","article-title":"Organoids: a new in vitro model system for biomedical science and disease modelling and promising source for cell-based transplantation","volume":"420","author":"Koo","year":"2016","journal-title":"Dev. Biol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0300","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nprot.2014.020","article-title":"Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant","volume":"9","author":"Takebe","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molmed.2018.06.009_bib0305","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.stem.2008.09.002","article-title":"Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals","volume":"3","author":"Eiraku","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0310","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2018.06.009_bib0315","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.stem.2012.05.009","article-title":"Self-formation of optic cups and storable stratified neural retina from human ESCs","volume":"10","author":"Nakano","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0320","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm.3737","article-title":"An in vivo model of human small intestine using pluripotent stem cells","volume":"20","author":"Watson","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2018.06.009_bib0325","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05098","article-title":"In vitro generation of human pluripotent stem cell derived lung organoids","volume":"4","author":"Dye","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2018.06.009_bib0330","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.aaf5211","article-title":"Replication of human noroviruses in stem cell-derived human enteroids","volume":"353","author":"Ettayebi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2018.06.009_bib0335","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","article-title":"Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure","volume":"165","author":"Qian","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0340","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.aaf6116","article-title":"Zika virus impairs growth in human neurospheres and brain organoids","volume":"352","author":"Garcez","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2018.06.009_bib0345","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2018.06.009_bib0350","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0355","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0360","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2018.06.009_bib0365","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.stemcr.2017.09.014","article-title":"Mouse genetic analysis of bone marrow stem cell niches: technological pitfalls, challenges, and translational considerations","volume":"9","author":"Chen","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2018.06.009_bib0370","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cell.2014.02.013","article-title":"Nice neighborhood: emerging concepts of the stem cell niche","volume":"157","author":"Scadden","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0375","first-page":"7","article-title":"The relationship between the spleen colony-forming cell and the haemopoietic stem cell","volume":"4","author":"Schofield","year":"1978","journal-title":"Blood Cells"},{"key":"10.1016\/j.molmed.2018.06.009_bib0380","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/stem.2711","article-title":"Concise review: conceptualizing paralogous stem-cell niches and unfolding bone marrow progenitor cell identities","volume":"36","author":"Chen","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2018.06.009_bib0385","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm.1951","article-title":"Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche","volume":"15","author":"Ootani","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2018.06.009_bib0390","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2018.06.009_bib0395","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrg837","article-title":"Regulatory phases of early liver development: paradigms of organogenesis","volume":"3","author":"Zaret","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2018.06.009_bib0400","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear receptors and lipid physiology: opening the X-files","volume":"294","author":"Chawla","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molmed.2018.06.009_bib0405","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome p450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0410","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cbpa.2013.01.028","article-title":"Engineering and application of P450 monooxygenases in pharmaceutical and metabolite synthesis","volume":"17","author":"Caswell","year":"2013","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0415","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/biof.1136","article-title":"ATP-binding cassette transporters in liver","volume":"40","author":"Wlcek","year":"2014","journal-title":"Biofactors"},{"key":"10.1016\/j.molmed.2018.06.009_bib0420","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2018.06.009_bib0425","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease","volume":"71","author":"Borst","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.molmed.2018.06.009_bib0430","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.genom.6.080604.162122","article-title":"Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates","volume":"6","author":"Dean","year":"2005","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.molmed.2018.06.009_bib0435","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1152\/physrev.00035.2005","article-title":"Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins","volume":"86","author":"Deeley","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.molmed.2018.06.009_bib0440","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1158\/1078-0432.CCR-11-1590","article-title":"Molecular pathways: regulation and therapeutic implications of multidrug resistance","volume":"18","author":"Chen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2018.06.009_bib0445","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2018.06.009_bib0450","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.4161\/cc.3.12.1331","article-title":"Pharmacokinetic resistance to imatinib mesylate: role of the ABC drug pumps ABCG2 (BCRP) and ABCB1 (MDR1) in the oral bioavailability of imatinib","volume":"3","author":"Burger","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.molmed.2018.06.009_bib0455","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2004-04-1398","article-title":"Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)\/ABCG2 drug pump","volume":"104","author":"Burger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2018.06.009_bib0460","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1074\/jbc.272.9.5974","article-title":"Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins","volume":"272","author":"Chen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2018.06.009_bib0465","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1124\/mol.57.4.769","article-title":"Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335)","volume":"57","author":"Chen","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0470","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00232-005-0792-1","article-title":"Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux","volume":"206","author":"Loo","year":"2005","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0475","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molmed.2018.06.009_bib0480","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A \u201csilent\u201d polymorphism in the MDR1 gene changes substrate specificity","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.molmed.2018.06.009_bib0485","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2018.06.009_bib0490","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.celrep.2015.07.062","article-title":"Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs","volume":"12","author":"Firth","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2018.06.009_bib0495","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2018.06.009_bib0500","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcf.2008.03.009","article-title":"Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice","volume":"7","author":"Castellani","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.molmed.2018.06.009_bib0505","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8278","article-title":"Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis","volume":"8","author":"Dekkers","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2018.06.009_bib0510","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcf.2010.12.008","article-title":"Splicing defects in the CFTR gene: minigene analysis of two mutations, 1811+1G>C and 1898+3A>G","volume":"10","author":"Dujardin","year":"2011","journal-title":"J. Cyst. Fibros."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491418301369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491418301369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T11:20:11Z","timestamp":1535023211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491418301369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":102,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1471491418301369"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2018.06.009","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pluripotent Stem Cell Platforms for Drug Discovery","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2018.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}